MESM (Minimally Invasive Electro Septal Myectomy) is a minimally invasive operation for hypertrophic obstructive cardiomyopathy (HOCM) developed by cardiac surgeon Dr. Yong Cui. Through a single right axillary incision of approximately 5 cm and a transaortic approach, the surgeon uses electrocautery to sculpt the hypertrophied septal muscle. The procedure also allows assessment of the papillary muscles, chordae and mitral leaflets that may contribute to obstruction, with treatment tailored to the patient's anatomy. The sternum is not divided; the incision and resulting scar are located in the axilla.
A right axillary incision without sternotomy
MESM uses a single incision of approximately 5 cm in the right axilla. The scar is positioned beneath the arm and may be less conspicuous when the arm is at rest. Its appearance and visibility vary with healing, arm position and clothing.
Visualization, electro-excision and anatomical assessment
MESM combines septal myectomy with a minimally invasive transaortic approach.
- Visualization. The right axillary route provides an endoscopic view through the aortic valve into the left ventricle, supporting assessment of the septum and relevant mitral and subvalvular structures.
- Electro-excision. Electrocautery is used to sculpt the hypertrophied septal muscle.
- Anatomical assessment. Direct visualization supports assessment of septal hypertrophy, abnormal connections and muscle bundles, papillary muscles, mitral leaflets and chordae. Any additional intervention is selected according to the individual anatomy and findings.
Addressing contributing structures
The team assesses both septal hypertrophy and mitral or subvalvular anatomy that may contribute to obstruction.
- Septal myectomy. The hypertrophied ventricular septal muscle is sculpted by electro-excision.
- Mitral and subvalvular intervention. When indicated, procedures may include anterior leaflet plication or shortening, papillary muscle realignment, or release of restrictive secondary chordae.
- Concomitant atrial fibrillation. Surgical ablation, including a Maze procedure, may be considered through the same access in selected patients. Anticoagulation decisions require individual assessment by the treating team; undergoing ablation does not by itself establish that anticoagulation can be stopped.
- Combined procedures. Additional valve or other cardiac procedures may be considered in selected patients. Their feasibility and appropriateness require assessment by the surgical team.
Intraoperative assessment
The intraoperative assessment includes septal thickness, abnormal connections and muscle bundles, papillary muscles, mitral leaflets and chordae, followed by transesophageal echocardiography (TEE) re-evaluation. If systolic anterior motion (SAM) persists, the team reassesses the anatomy and considers targeted mitral or subvalvular repair where indicated.